Stimulation of P2Y-purinoceptors on astrocytes results in immediate early gene expression and potentiation of neuropeptide action

Neuroscience. 1998 Jul;85(2):521-5. doi: 10.1016/s0306-4522(97)00653-2.

Abstract

The action of adenosine-5'-O-(2-thiodiphosphate), a non-hydrolysable purine analogue and potent P2Y1-purinoceptor agonist, was studied on immediate early gene expression in rat astrocyte cultures. A rapid and transient increase in c-fos, junB, c-jun and Tis11 messenger RNA was observed in cultured astrocytes after treatment with adenosine-5'-O-(2-thiodiphosphate). Maximal induction of immediate early gene expression was obtained within 30 min of stimulation and c-fos was the most sensitive indicator of P2Y-purinoceptor activation. Calcitonin gene-related peptide has also been shown to be a potent inducer of c-fos messenger RNA in cultured astroglial cells. The combined stimulation of astrocytes with calcitonin gene-related peptide and adenosine-5'-O-(2-thiodiphosphate) resulted in the potentiated expression of c-fos messenger RNA. The superinduction of immediate early gene expression by calcitonin gene-related peptide and extracellular ATP in cultured astrocytes might result from intracellular signal transduction cross-talk, since adenosine-5'-O-(2-thiodiphosphate) was found to increase calcitonin gene-related peptide-induced cyclic AMP accumulation by 35%. Phorbol 12-myristate 13-acetate also increased calcitonin gene-related peptide-evoked cyclic AMP accumulation and led to the induction of immediate early gene expression, suggesting that protein kinase C might be at least in part involved in purinergic cross-talk. Our results demonstrate synergistic roles for extracellular ATP and calcitonin gene-related peptide in the transcriptional activation of astroglial cells.

Publication types

  • Comparative Study

MeSH terms

  • Adenosine Diphosphate / analogs & derivatives
  • Adenosine Diphosphate / pharmacology
  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Calcitonin Gene-Related Peptide / pharmacology
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • DNA-Binding Proteins*
  • Drug Synergism
  • Gene Expression Regulation / drug effects*
  • Genes, Immediate-Early / drug effects*
  • Genes, fos / drug effects
  • Genes, jun / drug effects
  • Immediate-Early Proteins*
  • Neuropeptides / drug effects*
  • Neuropeptides / pharmacology*
  • Proteins / genetics
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Wistar
  • Receptors, Purinergic P2 / metabolism*
  • Receptors, Purinergic P2 / physiology
  • Receptors, Purinergic P2Y1
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thionucleotides / pharmacology
  • Tristetraprolin

Substances

  • DNA-Binding Proteins
  • Immediate-Early Proteins
  • Neuropeptides
  • P2ry1 protein, rat
  • Proteins
  • RNA, Messenger
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y1
  • Thionucleotides
  • Tristetraprolin
  • Zfp36 protein, rat
  • adenosine 5'-O-(1-thiodiphosphate)
  • Adenosine Diphosphate
  • Cyclic AMP
  • Calcitonin Gene-Related Peptide
  • Tetradecanoylphorbol Acetate